Piramal Pharma(PPLPHARMA.NS)
Focus: Piramal Pharma is a public CDMO and specialty pharmaceutical company headquartered in Mumbai, operating at scale with 5,001–10,000 employees. The company generates 47% of revenue from ASPRUZYO SPRINKLE (ranolazine), indicating heavy concentration in a single branded product.
Profile data last refreshed 9h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Employees
5001-10000
Open Jobs
0
About Piramal Pharma
AI assessmentNot HiringNo open roles listed right now. Follow Piramal Pharma to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Late-stage
3 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Key Products
$139K Part DStable
Peak11.5yr
Anchor product generating 47% of company revenue; LOE protection extends to 2038, but concentrated revenue exposure is a career risk if competitive pressures emerge.
Help build intelligence for Piramal Pharma
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.